Myocardial expression of fas and recovery of left ventricular function in patients with recent-onset cardiomyopathy

Journal of the American College of Cardiology

Volumn 46, Issue 6, 2005, Pages 1036-1042

  Sheppard, Richard ^a   Bedi, Maninder ^b   Kubota, Toru ^c   Semigran, Marc J ^d   Dec, William ^d   Holubkov, Richard ^e   Feldman, Arthur M ^f   Rosenblum, Warren D ^g   McTiernan, Charles F ^b   McNamara, Dennis M ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c KYUSHU UNIVERSITY   (Japan)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONVALESCENCE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIBONUCLEASE PROTECTION ASSAY;

ADULT; ANTIGENS, CD95; CARDIOMYOPATHIES; FAS LIGAND PROTEIN; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOVERY OF FUNCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 24944548318     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.05.067     Document Type: Article

References (24)

1. G.W. Dec, I.F. Palacios, J.T. Fallon Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome N Engl J Med 312 1985 885 890
2. A.E. Steimle, L.W. Stevenson, G.C. Fonarow Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation J Am Coll Cardiol 23 1994 553 559
3. G.W. Dec, V. Fuster Idiopathic dilated cardiomyopathy N Engl J Med 331 1994 1564 1575
4. A. Hanustetter, S. Izuma Apoptosis basic mechanisms and implications for cardiovascular disease Circ Res 82 1998 1111 1129
5. J. Narula, N. Haider, R. Virmani Apoptosis in myocytes in end-stage heart failure N Engl J Med 335 1996 1182 1189
6. G. Olivetti, R. Abbi, F. Quaini Apoptosis in the failing heart N Engl J Med 336 1997 1131 1141
7. T. Toyozaki, M. Hiroe, M. Tanaka Levels of soluble Fas ligand in myocarditis Am J Cardiol 82 1998 246 248
8. S. Yamaguchi, M. Yamaoka, M. Okuyama Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure Am J Cardiol 83 1999 1500 1503
9. H. Kawakami, Y. Shigematsu, T. Ohtsuka Increased circulating soluble form of Fas in patients with dilated cardiomyopathy Jpn Circ J 62 1998 873 876
10. T. Toyozaki, M. Hiroe, T. Saito Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers Am J Cardiol 81 1998 798 800
11. T. Tsutamoto, A. Wada, K. Maeda Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas plasma soluble Fas as a prognostic predictor in patients with congestive heart failure J Card Fail 7 2001 322 328
12. D.M. McNamara, R. Holubkov, R.C. Starling Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy Circulation 103 2001 2254 2259
13. D.M. McNamara, W.D. Rosenblum, K.M. Janosko Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy Circulation 95 1997 2476 2478
14. J. Mason, J.B. O'Connell, A. Herskowitz A clinical trial of immunosuppressive therapy for myocarditis N Engl J Med 333 1995 269 275
15. R.E. McCarthy, J.P. Boehmer, R. Hruban Long-term outcome of fulminant myocarditis as compared with acute (non-fulminant) myocarditis N Engl J Med 34 2000 690 695
16. S. Ishiyama, M. Hiroe, T. Nishikawa The Fas/Fas ligand system is involved in the pathogenesis of autoimmune myocarditis in rats J Immunol 161 1998 4695 4701
17. K. Sliwa, D. Skudicky, A. Bergemann Peripartum cardiomyopathy analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1 J Am Coll Cardiol 35 2000 701 705
18. O. Micheau, J. Tschopp Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes Cell 114 2003 181 190
19. I. Toda, B.D. Sullivan, L.A. Wickham, D.A. Sullivan Gender-and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoimmune and non-autoimmune mice J Steroid Biochem Mol Biol 71 1999 49 61
20. D. Verzola, M.T. Gandolfo, F. Salvatore Testosterone promotes apoptotic damage in human renal tubular cells Kidney Int 65 2004 1252 1261
21. M. Wang, B.M. Tsai, A. Kher, L.B. Baker, G.M. Wairiuko, D.R. Meldrum Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion Am J Physiol Heart Circ Physiol 288 2005 H221 H226
22. G.W. Dec, V. Fuster Idiopathic dilated cardiomyopathy N Engl J Med 331 1994 1564 1575
23. T. Kubota, M. Miyagishima, R. Alvarez Expression of proinflammatory cytokines in the failing human heart comparison of recent-onset and end-stage congestive heart failure J Heart Lung Transplant 19 2000 819 824
24. B.D. Lowes, W. Minobe, W.T. Abraham Changes in gene expression in the intact human heart downregulation of alpha-myosin heavy chain in hypertrophied, failing, ventricular myocardium J Clin Invest 100 1997 2315 2324